ACI
CPRX icon

AMP Capital Investors’s Catalyst Pharmaceutical CPRX Stock Holding History

AMP Capital Investors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-71,251
Closed -$244K – 1239
2020
Q4 		$244K Sell
71,251
-14,238
-17% -$47.8K ﹤0.01% 1153
2020
Q3 		$274K Hold
85,489
– – ﹤0.01% 1074
2020
Q2 		$390K Hold
85,489
– – ﹤0.01% 971
2020
Q1 		$331K Buy
85,489
+63,677
+292% +$261K ﹤0.01% 953
2019
Q4 		$80K Buy
+21,812
New +$102K ﹤0.01% 1174

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AMP Capital Investors's CPRX Position: Q1 2021 in Review

AMP Capital Investors sold out of Catalyst Pharmaceutical (CPRX) in Q1 2021, closing a stake of 71,251 shares — an estimated $244K sold.

AMP Capital Investors first reported a position in CPRX in Q4 2019 and held it in 5 quarters. The position peaked at $390K in Q2 2020. 133 funds tracked by Wall St. Rank hold CPRX as of Q1 2021.

  • AMP Capital Investors reported no remaining Catalyst Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • AMP Capital Investors sold 71,251 Catalyst Pharmaceutical shares in Q1 2021, an estimated $244K.
  • AMP Capital Investors first reported a position in Catalyst Pharmaceutical in Q4 2019 and held it in 5 quarters.
  • AMP Capital Investors's Catalyst Pharmaceutical position peaked at $390K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2021.

Based on AMP Capital Investors's 13F filing for Q1 2021, filed 17 May 2021.